FSH and LH together in ovarian stimulation

Paolo E. Levi-Setti, Mario Cavagna, Annamaria Baggiani, Elena Zannoni, Giulia V. Colombo, Valeria Liprandi

Research output: Contribution to journalArticle

Abstract

The authors review the physiology of the ovulatory cycle and the role of the gonadotrophins in ovulation induction in patients with anovulatory disorders and in multifollicular development for assisted reproductive technologies. The use of gonadotrophins with luteinizing hormone (LH) activity and the use of recombinant LH associated with follicle stimulating hormone (FSH) are discussed. The authors point out that administration of gonadotrophins with LH activity is essential in hypogonadotropic hypogonadal anovulation, and data available in the medical literature allow the conclusion that recombinant LH may be added to all ovarian stimulation protocols because it is difficult to determine which patients will benefit from LH administration and there is no evidence that LH affects adversely the outcome of ovarian stimulation. The use of recombinant LH in addition to recombinant FSH may be particularly useful when a GnRH antagonist is associated with the ovarian stimulation regimen, by preventing the fall in estradiol and diminishing FSH requirements.

Original languageEnglish
JournalEuropean Journal of Obstetrics and Gynecology and Reproductive Biology
Volume115
Issue numberSUPPL.
DOIs
Publication statusPublished - Jul 1 2004

Fingerprint

Ovulation Induction
Follicle Stimulating Hormone
Luteinizing Hormone
Gonadotropins
Anovulation
Assisted Reproductive Techniques
Gonadotropin-Releasing Hormone
Estradiol

Keywords

  • Folliculogenesis
  • hMG
  • Ovarian stimulation
  • Recombinant FSH
  • Recombinant LH

ASJC Scopus subject areas

  • Obstetrics and Gynaecology
  • Reproductive Medicine

Cite this

FSH and LH together in ovarian stimulation. / Levi-Setti, Paolo E.; Cavagna, Mario; Baggiani, Annamaria; Zannoni, Elena; Colombo, Giulia V.; Liprandi, Valeria.

In: European Journal of Obstetrics and Gynecology and Reproductive Biology, Vol. 115, No. SUPPL., 01.07.2004.

Research output: Contribution to journalArticle

Levi-Setti, Paolo E. ; Cavagna, Mario ; Baggiani, Annamaria ; Zannoni, Elena ; Colombo, Giulia V. ; Liprandi, Valeria. / FSH and LH together in ovarian stimulation. In: European Journal of Obstetrics and Gynecology and Reproductive Biology. 2004 ; Vol. 115, No. SUPPL.
@article{d25e9ebb8e134065ad47bc6e94412c07,
title = "FSH and LH together in ovarian stimulation",
abstract = "The authors review the physiology of the ovulatory cycle and the role of the gonadotrophins in ovulation induction in patients with anovulatory disorders and in multifollicular development for assisted reproductive technologies. The use of gonadotrophins with luteinizing hormone (LH) activity and the use of recombinant LH associated with follicle stimulating hormone (FSH) are discussed. The authors point out that administration of gonadotrophins with LH activity is essential in hypogonadotropic hypogonadal anovulation, and data available in the medical literature allow the conclusion that recombinant LH may be added to all ovarian stimulation protocols because it is difficult to determine which patients will benefit from LH administration and there is no evidence that LH affects adversely the outcome of ovarian stimulation. The use of recombinant LH in addition to recombinant FSH may be particularly useful when a GnRH antagonist is associated with the ovarian stimulation regimen, by preventing the fall in estradiol and diminishing FSH requirements.",
keywords = "Folliculogenesis, hMG, Ovarian stimulation, Recombinant FSH, Recombinant LH",
author = "Levi-Setti, {Paolo E.} and Mario Cavagna and Annamaria Baggiani and Elena Zannoni and Colombo, {Giulia V.} and Valeria Liprandi",
year = "2004",
month = "7",
day = "1",
doi = "10.1016/j.ejogrb.2004.01.013",
language = "English",
volume = "115",
journal = "European Journal of Obstetrics, Gynecology and Reproductive Biology",
issn = "0028-2243",
publisher = "Elsevier Ireland Ltd",
number = "SUPPL.",

}

TY - JOUR

T1 - FSH and LH together in ovarian stimulation

AU - Levi-Setti, Paolo E.

AU - Cavagna, Mario

AU - Baggiani, Annamaria

AU - Zannoni, Elena

AU - Colombo, Giulia V.

AU - Liprandi, Valeria

PY - 2004/7/1

Y1 - 2004/7/1

N2 - The authors review the physiology of the ovulatory cycle and the role of the gonadotrophins in ovulation induction in patients with anovulatory disorders and in multifollicular development for assisted reproductive technologies. The use of gonadotrophins with luteinizing hormone (LH) activity and the use of recombinant LH associated with follicle stimulating hormone (FSH) are discussed. The authors point out that administration of gonadotrophins with LH activity is essential in hypogonadotropic hypogonadal anovulation, and data available in the medical literature allow the conclusion that recombinant LH may be added to all ovarian stimulation protocols because it is difficult to determine which patients will benefit from LH administration and there is no evidence that LH affects adversely the outcome of ovarian stimulation. The use of recombinant LH in addition to recombinant FSH may be particularly useful when a GnRH antagonist is associated with the ovarian stimulation regimen, by preventing the fall in estradiol and diminishing FSH requirements.

AB - The authors review the physiology of the ovulatory cycle and the role of the gonadotrophins in ovulation induction in patients with anovulatory disorders and in multifollicular development for assisted reproductive technologies. The use of gonadotrophins with luteinizing hormone (LH) activity and the use of recombinant LH associated with follicle stimulating hormone (FSH) are discussed. The authors point out that administration of gonadotrophins with LH activity is essential in hypogonadotropic hypogonadal anovulation, and data available in the medical literature allow the conclusion that recombinant LH may be added to all ovarian stimulation protocols because it is difficult to determine which patients will benefit from LH administration and there is no evidence that LH affects adversely the outcome of ovarian stimulation. The use of recombinant LH in addition to recombinant FSH may be particularly useful when a GnRH antagonist is associated with the ovarian stimulation regimen, by preventing the fall in estradiol and diminishing FSH requirements.

KW - Folliculogenesis

KW - hMG

KW - Ovarian stimulation

KW - Recombinant FSH

KW - Recombinant LH

UR - http://www.scopus.com/inward/record.url?scp=2942601134&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=2942601134&partnerID=8YFLogxK

U2 - 10.1016/j.ejogrb.2004.01.013

DO - 10.1016/j.ejogrb.2004.01.013

M3 - Article

C2 - 15196714

AN - SCOPUS:2942601134

VL - 115

JO - European Journal of Obstetrics, Gynecology and Reproductive Biology

JF - European Journal of Obstetrics, Gynecology and Reproductive Biology

SN - 0028-2243

IS - SUPPL.

ER -